LISOLOG Trademark

Trademark Overview

On Friday, January 29, 2021, a trademark application was filed for LISOLOG with the United States Patent and Trademark Office. The USPTO has given the LISOLOG trademark a serial number of 90496944. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, March 5, 2024. This trademark is owned by Wockhardt Bio AG. The LISOLOG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing insulin for the treatment and prevention of diabetes; inhalers filled with insulin
lisolog

General Information

Serial Number90496944
Word MarkLISOLOG
Filing DateFriday, January 29, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, March 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 20, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations containing insulin for the treatment and prevention of diabetes; inhalers filled with insulin

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWockhardt Bio AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZug Zug
CH
Party NameWockhardt Bio AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZug Zug
CH

Trademark Events

Event DateEvent Description
Wednesday, March 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 5, 2024SOU EXTENSION 5 GRANTED
Tuesday, March 5, 2024SOU EXTENSION 5 FILED
Tuesday, March 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 1, 2023SOU EXTENSION 4 GRANTED
Friday, September 1, 2023SOU EXTENSION 4 FILED
Friday, September 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 21, 2023ASSIGNED TO EXAMINER
Wednesday, March 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 13, 2023SOU EXTENSION 3 GRANTED
Monday, March 13, 2023SOU EXTENSION 3 FILED
Monday, March 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 6, 2022SOU EXTENSION 2 GRANTED
Tuesday, September 6, 2022SOU EXTENSION 2 FILED
Tuesday, September 6, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 17, 2022SOU EXTENSION 1 GRANTED
Monday, March 14, 2022SOU EXTENSION 1 FILED
Tuesday, May 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 19, 2022NOTICE OF REVIVAL - E-MAILED
Tuesday, April 19, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, April 19, 2022PETITION TO REVIVE-GRANTED
Tuesday, April 19, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, April 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 18, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 30, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 12, 2021ASSIGNED TO EXAMINER
Saturday, May 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 2, 2021NEW APPLICATION ENTERED

Related Keywords

lisolog insulin diabetes inhalers filled prevention treatment preparations containing pharmaceutical